A simple ultrafiltration method for determining unbound estradiol in serum

Area of Science:

• Endocrinology
• Biochemistry
• Analytical Chemistry

Background:

• Accurate measurement of free estradiol-17 beta is crucial for understanding reproductive health and endocrine disorders.
• Existing methods for determining free estradiol-17 beta can be time-consuming or require larger sample volumes.

Purpose of the Study:

• To develop and validate a rapid, practicable, and reproducible assay for free estradiol-17 beta in human serum.
• To compare the performance of the new assay with established methods like equilibrium dialysis.

Main Methods:

• Utilized the Amicon MPS-1 centrifugal ultrafiltration device and YMT membrane for serum ultrafiltration.
• Employed a two-assay system measuring total estradiol-17 beta and the ultrafiltrable fraction.
• Quantified unbound [3H]estradiol-17 beta in ultrafiltrates after equilibration with serum.

Main Results:

• The developed assay is rapid (1 hour), requires minimal serum (0.6 mL), and demonstrates high reproducibility (CV 4.6% within-assay, 6.5% between-assay).
• Results from the ultrafiltration assay correlated well with those obtained by equilibrium dialysis in healthy men, women, and pregnant women.
• Free estradiol-17 beta levels showed no significant difference between early and late follicular phases but differed significantly between males and females.

Conclusions:

• Centrifugal ultrafiltration offers a viable alternative for measuring free estradiol-17 beta, providing accurate and reproducible results.
• The assay's practicality and speed make it suitable for clinical and research applications.
• Further investigation into estradiol-17 beta levels in conditions like hirsutism may benefit from this improved methodology.